These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6475839)

  • 1. Trials of commercial reagents in anion-exchange coagulation procedures: ortho diagnostics.
    Branson HE; Schottinger JE; Fagin AR; Puri SL; Roohk V
    Am J Clin Pathol; 1984 Oct; 82(4):432-5. PubMed ID: 6475839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated partial thromboplastin time after heparin removal (aPTT/HR) in a new scheme of anticoagulant monitoring.
    Branson HE; Gupta N; Slater LM; Fagin A; Armentrout SA
    Am J Hematol; 1982 Jun; 12(4):411-8. PubMed ID: 7114053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of activated partial thromboplastin time to monitor coumarin anticoagulation.
    Branson HE; Sapra R; Roohk V; Fagin A; Arronte M
    J Natl Med Assoc; 1983 Jan; 75(1):61-4. PubMed ID: 6827599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in heparin sensitivity of APTT reagents.
    Bjornsson TD; Nash PV
    Am J Clin Pathol; 1986 Aug; 86(2):199-204. PubMed ID: 3739971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
    Shapiro GA; Huntzinger SW; Wilson JE
    Am J Clin Pathol; 1977 May; 67(5):477-80. PubMed ID: 857645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two APTT reagents which use silica activators.
    Ray MJ; Hawson GA
    Clin Lab Haematol; 1989; 11(3):221-32. PubMed ID: 2556232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT.
    D'Angelo A; Seveso MP; D'Angelo SV; Gilardoni F; Dettori AG; Bonini P
    Am J Clin Pathol; 1990 Sep; 94(3):297-306. PubMed ID: 2396604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study.
    Guddorf V; Kummerfeld N; Mischke R
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time.
    Banez EI; Triplett DA; Koepke J
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):569-74. PubMed ID: 7435450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
    Turi DC; Peerschke EI
    Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
    Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
    Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
    van den Besselaar AM; Meeuwisse-Braun J
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):635-8. PubMed ID: 8218862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unwarranted use of replicate analysis in routine coagulation studies.
    Sage-el A; Burns E; Wenz B
    Am J Clin Pathol; 1985 Jan; 83(1):81-3. PubMed ID: 3966443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
    Robert A
    Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.